GLUU Glu Mobile Inc.

Glu Announces Sale of Its Moscow Studio

Glu Mobile Inc. (NASDAQ: GLUU), a leading developer and publisher of mobile games, today announced it has completed the divestiture of its Moscow studio along with the sale of several titles developed by that location. Glu will receive aggregate consideration of approximately $4.5 million, consisting of $3 million in cash and the assumption of approximately $1.5 million in minimum guaranteed royalty payments.

Originally acquired in 2008, Glu’s Moscow studio has focused on the development and live operations of shooter and action games including the Contract Killer, Frontline Commando, and Blood & Glory franchises, all of which will be transitioned to Glu’s Hyderabad, India studio. Glu Moscow was also managing live operations for Deer Hunter 2017, which will transition to Hyderabad, where Deer Hunter Classic currently is operated. The parties have agreed to transition each of these titles to Hyderabad by March 31, 2018.

The assets sold by Glu include the Last Day Alive mobile game currently in beta, the Heroes of Destiny mobile game previously published by Glu, the celebrity license agreement for a previously disclosed unnamed male celebrity and the corresponding mobile game in the prototype stage. Glu has also agreed to provide a non-exclusive license to use certain tools and technology necessary for further development of the purchased games.

“This transaction is consistent with our strategy to consolidate development operations to our creative centers located in North America. As we enter 2018, we are focused on driving increased creativity and collaboration in Glu’s remaining studios,” said Nick Earl, Glu’s President and Chief Executive Officer. “I would like to thank the talented team in Moscow for their contributions to Glu’s success and I am confident they will continue to thrive under new leadership.”

“Over the last 18 months we have expanded our North America and India locations while eliminating studios in Beijing, Bellevue, Portland, Long Beach, and Moscow. These initiatives have allowed us to focus on a scaled creative center in San Francisco and a low cost, repeatable location in Hyderabad,” said Eric R. Ludwig, Glu’s Chief Operating Officer and Chief Financial Officer. “Our prior statements about our lower operating expense profile in 2018 assumed this transaction would be completed by the end of 2017.”

Cautions Regarding Forward-Looking Statements

This press release contains certain “forward-looking statements” related to the business of Glu Mobile Inc., including statements that Glu intends to transition certain games developed and/or operated by its Moscow studio to its Hyderabad studio by March 31, 2018; that Glu is focused on driving increased creativity and collaboration in its remaining studios; and that Glu expects to achieve a lower expense profile in 2018 compared with 2017. Such forward-looking statements involve known and unknown risks and uncertainties, including, but not limited to, the risk that we do not realize the expected benefits from the divestiture of our Moscow studio; the risk that consumer demand for smartphones, tablets and next-generation platforms does not grow as significantly as we anticipate or that we will be unable to capitalize on any such growth; and the risk that we do not realize a sufficient return on our investment with respect to our efforts to develop free-to-play games for smartphones, tablets and next-generation platforms. Certain of these risks and uncertainties are or will be described in greater detail in our public filings with the SEC. Glu is not under obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

About Glu Mobile

Glu Mobile (NASDAQ: GLUU) is a leading developer and publisher of mobile games. Glu is focused on creating compelling original IP games such as, COOKING DASH, COVET FASHION, DEER HUNTER, DESIGN HOME, QUIZUP, and RACING RIVALS, and branded IP games including, THE SWIFT LIFE, MLB TAP SPORTS BASEBALL 2017 and KIM KARDASHIAN: HOLLYWOOD on the App Store, Google Play and Amazon Appstore. Founded in 2001, Glu is headquartered in San Francisco with U.S. offices in Burlingame and San Mateo and international locations in Canada and India. Consumers can find high-quality entertainment wherever they see the ‘g’ character logo or at www.glu.com.

For live updates, please follow Glu via Twitter at www.twitter.com/glumobile and on Instagram at www.instagram.com/glumobile, or become a Glu fan at www.facebook.com/glumobile.

COOKING DASH, COVET FASHION, DEER HUNTER, QUIZUP, RACING RIVALS, TAP SPORTS, GLU, GLU MOBILE, and the 'g' character logo are trademarks of Glu Mobile Inc.

EN
05/01/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Glu Mobile Inc.

Wedbush Research
  • Wedbush Research
2454 MEDIATEK CORPORATION
UBI UBISOFT ENTERTAINMENT SA
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
BLUE BLUEBIRD BIO INC.
XOMA XOMA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TPH TRI POINTE HOMES INC.
STX SEAGATE TECHNOLOGY PLC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MGNX MACROGENICS INC.
LGIH LGI HOMES INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
KBH KB HOME
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GME GAMESTOP CORP. CLASS A
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
ATVI ACTIVISION BLIZZARD INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
ALXN ALEXION PHARMACEUTICALS INC.
AGTC APPLIED GENETIC TECHNOLOGIES
ABUS ARBUTUS BIOPHARMA CORP.
MRVL MARVELL TECHNOLOGY GROUP LTD.
SWKS SKYWORKS SOLUTIONS INC.
DOOR MASONITE INTERNATIONAL CORP.
5425 TAIWAN SEMICONDUCTOR CO. LTD.
7974 NINTENDO CO. LTD.
BLDR BUILDERS FIRSTSOURCE INC.
EA ELECTRONIC ARTS INC.
GLUU GLU MOBILE INC.
TMHC TAYLOR MORRISON HOME CORPORATION
ZNGA ZYNGA INC. CLASS A
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ANGI ANGI INC. CLASS A
ARGX ARGEN-X SE
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
AVRO AVROBIO
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
MGTA MAGENTA THERAPEUTICS
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
RGLS REGULUS THERAPEUTICS
TCRR TCR2 THERAPEUTICS
LYFT LYFT
ORTX ORCHARD RX ADS
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
UBER UBER TECHNOLOGIES INC.
IMUX IMMUNIC INC
SCPL SCIPLAY
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
AXLA AXCELLA HEALTH
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
FUSN INC.
U FUSION PHARMACEUTICALS INC
ACET UNITY SOFTWARE INC.
GRAY ADICET BIO
PASG INC
IAC GRAYBUG VISION
FRLN INC
ITOS PASSAGE BIO
INZY IAC/INTERACTIVECORP.
CDAK FREELINE THERAPEUTICS HOLDINGS ADS
ZNTL ITEOS THERAPEUTICS
BEAM INOZYME PHARMA
GBIO CODIAK BIOSCIENCES
PRAX INC.
FHTX ZENTALIS PHARMACEUTICALS
COGT BEAM THERAPEUTICS
TVTX GENERATION BIO
KNTE PRAXIS PRECISION MEDICINES
SKLZ FOGHORN THERAPEUTICS
PLTK INC.
COGENT BIOSCIENCES INC
TRAVERE THERAPEUTICS INC
KINNATE BIOPHARMA
SKILLZ INC (A)
PLAYTIKA HOLDING
Wedbush Research
  • Wedbush Research
2454 MEDIATEK CORPORATION
UBI UBISOFT ENTERTAINMENT SA
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
HZO MARINEMAX INC.
BLUE BLUEBIRD BIO INC.
XOMA XOMA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
STX SEAGATE TECHNOLOGY PLC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NUAN NUANCE COMMUNICATIONS INC.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MGNX MACROGENICS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
ATVI ACTIVISION BLIZZARD INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ALXN ALEXION PHARMACEUTICALS INC.
AGTC APPLIED GENETIC TECHNOLOGIES
ACOR ACORDA THERAPEUTICS INC.
ABUS ARBUTUS BIOPHARMA CORP.
MRVL MARVELL TECHNOLOGY GROUP LTD.
BC BRUNSWICK CORPORATION
SWKS SKYWORKS SOLUTIONS INC.
5425 TAIWAN SEMICONDUCTOR CO. LTD.
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
GLUU GLU MOBILE INC.
ZNGA ZYNGA INC. CLASS A
HPE HEWLETT PACKARD ENTERPRISE CO.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ARGX ARGEN-X SE
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
AVRO AVROBIO
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
MGTA MAGENTA THERAPEUTICS
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
RGLS REGULUS THERAPEUTICS
TCRR TCR2 THERAPEUTICS
ORTX ORCHARD RX ADS
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
IMUX IMMUNIC INC
SCPL SCIPLAY
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
AXLA AXCELLA HEALTH
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
FUSN INC.
ACET FUSION PHARMACEUTICALS INC
GRAY ADICET BIO
PASG INC
FRLN GRAYBUG VISION
ITOS INC
INZY PASSAGE BIO
CDAK FREELINE THERAPEUTICS HOLDINGS ADS
ZNTL ITEOS THERAPEUTICS
BEAM INOZYME PHARMA
GBIO CODIAK BIOSCIENCES
PRAX INC.
FHTX ZENTALIS PHARMACEUTICALS
COGT BEAM THERAPEUTICS
TVTX GENERATION BIO
KNTE PRAXIS PRECISION MEDICINES
PLTK FOGHORN THERAPEUTICS
INC.
COGENT BIOSCIENCES INC
TRAVERE THERAPEUTICS INC
KINNATE BIOPHARMA
PLAYTIKA HOLDING

ResearchPool Subscriptions

Get the most out of your insights

Get in touch